Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Moxifloxacin ophthalmic (0.5% USP),Prophylaxisis of post-operative endophthalmitis (POE) following intra-ocular surgery.,Moxifloxacin ophthalmic (0.5% USP) (Vigamox),,Community and Hospital,
